These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1524018)

  • 21. [Conservative therapy of ulcerative colitis--long-term experience].
    Kölbel C; Goebell H
    Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 23. A rational approach to 5-aminosalicylic acid therapy in ulcerative colitis.
    Miner PB; Peppercorn MA; Targan SR
    Hosp Pract (Off Ed); 1993 Dec; 28 Suppl 3():1-24. PubMed ID: 8270648
    [No Abstract]   [Full Text] [Related]  

  • 24. 5-ASA enema therapy.
    Hanauer SB
    Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current orientation in medical management of ulcerative colitis].
    Grassi M; Raffa S; Damiani VC; Fontana M
    Clin Ter; 1995 May; 146(5):327-41. PubMed ID: 7796565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current medical treatment of hemorrhagic rectocolitis].
    Gendre JP
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T9-12. PubMed ID: 7913901
    [No Abstract]   [Full Text] [Related]  

  • 28. [New treatments of hemorrhagic rectocolitis].
    Rambaud JC
    Ann Gastroenterol Hepatol (Paris); 1988; 24(4):173-7. PubMed ID: 2901821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease.
    Bondesen S; Rasmussen SN; Rask-Madsen J; Nielsen OH; Lauritsen K; Binder V; Hansen SH; Hvidberg EF
    Acta Med Scand; 1987; 221(3):227-42. PubMed ID: 3296672
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of action of 5-aminosalicylic acid and its derivatives.
    Ireland A; Jewell DP
    Clin Sci (Lond); 1990 Feb; 78(2):119-25. PubMed ID: 2155736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis.
    Abdullah AM; Scott RB; Martin SR
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):441-4. PubMed ID: 8145103
    [No Abstract]   [Full Text] [Related]  

  • 33. Ulcerative colitis.
    Am Pharm; 1992 Aug; NS32(8):27. PubMed ID: 1524018
    [No Abstract]   [Full Text] [Related]  

  • 34. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
    Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
    Kruis W
    Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.